Bioscience Today

28/02/2026

Researchers at University of Aberdeen have identified a potential new therapeutic target that could change how asthma is treated.

By uncovering previously underexplored biological pathways, the findings may support the development of more effective and targeted interventions for patients with chronic respiratory disease.

📖 Read the full story: https://www.biosciencetoday.co.uk/potential-new-therapeutic-target-for-asthma-discovered/

27/02/2026

Europa Biosite Acquires Stratech Scientific, Expanding Their Product Offering and Strengthening UK Customer Reach https://www.biosciencetoday.co.uk/europa-biosite-acquires-stratech-scientific-expanding-their-product-offering-and-strengthening-uk-customer-reach/

Europa Biosite, a leading pan-European life science distribution group, today announced the acquisition of Stratech Scientific Limited by its UK subsidiary, Cambridge Bioscience. Stratech Scientific is a well-respected and long-established UK life science distributor, known for its high-quality rese...

27/02/2026

Researchers at University of Bath have developed a peptide “switch” capable of stabilising a key Parkinson’s-related protein in its healthy form.

This breakthrough offers new insight into protein misfolding - a central factor in neurodegenerative disease - and may inform future therapeutic development strategies.

🧬 Discover more: https://www.biosciencetoday.co.uk/scientists-design-peptide-switch-that-keeps-parkinsons-protein-in-its-healthy-form/

26/02/2026

Innovative research into customised cell therapies, by scientists at University of Geneva and Hôpitaux Universitaires de Genève, is showing encouraging potential in the fight against aggressive brain cancers.

By engineering cells to more precisely recognise and attack tumour cells, scientists are moving closer to highly personalised oncology treatments that may improve survival outcomes.

🔬 Full article: https://www.biosciencetoday.co.uk/customised-cells-fight-brain-cancer/

25/02/2026

Transduction-ready viral particles https://www.biosciencetoday.co.uk/transduction-ready-viral-particles/

Amsbio offers a comprehensive range of pre-made lentiviral particles for delivering target genes into most types of dividing and non-dividing mammalian cells in vitro and in vivo. Lentiviral particles provide long-term, stable expression of genes, making them ideal for stable cell line engineering,....

25/02/2026

Scripta Therapeutics is advancing a novel approach to disease-modifying therapies, targeting underlying biological mechanisms rather than simply managing symptoms.

With a focus on precision and molecular innovation, the company aims to reshape how chronic and complex diseases are treated in the future.

🔗 Read the full story: https://www.biosciencetoday.co.uk/scripta-therapeutics-aims-to-flip-the-script-on-disease-modifying-drugs/

24/02/2026

Researchers from The University of Edinburgh have identified a promising new drug target that could help combat antimicrobial resistance - one of the most pressing global health threats.

By uncovering vulnerabilities in resistant pathogens, scientists are paving the way for next-generation therapies designed to overcome treatment failure and reduce the spread of infection.

🔬 Read more: https://www.biosciencetoday.co.uk/new-drug-target-identified-in-fight-against-resistant-infections/

23/02/2026

A lack of diversity in genomics research is limiting progress in dementia diagnosis and treatment. Neil Ward, VP of PacBio EMEA, highlights how expanding representation in genetic datasets could improve diagnostic accuracy, reduce health inequalities and accelerate personalised approaches to care.

As dementia cases continue to rise globally, addressing bias in research has become a scientific and ethical priority.

🔎 Read the full story: https://www.biosciencetoday.co.uk/breaking-the-bias-diverse-genomics-can-transform-dementia-diagnoses/

22/02/2026

Johannes Solzbach, CEO and co-founder at Calira, believes greater visibility of equipment usage data can help labs protect productivity without new investment https://www.biosciencetoday.co.uk/doing-more-with-less-in-rd-turning-equipment-usage-data-into-capex-efficiency/

As budgets tighten across life sciences, many R&D organisations have realised their biggest source of waste isn’t in their science, but their operations. Johannes Solzbach, CEO and co-founder at Calira, believes greater visibility of equipment usage data can help labs protect productivity without ...

21/02/2026

P*s are crucial to maintaining research integrity, says Dekel Faruhi, VP of Product Adoption at Proofig - Image Integrity In Scientific Publications https://www.biosciencetoday.co.uk/principal-investigators-the-fuel-of-scientific-progress/

P*s are crucial to maintaining research integrity, says Dekel Faruhi, VP of Product Adoption at Proofig AI. The path to becoming a Principal Investigator (PI) usually takes over a decade, beginning with undergraduate studies and culminating in the acquisition of independent research funding. Becomin...

20/02/2026

As scientists and researchers seek to integrate AI more deeply into daily lab workflows, tackling the issue of false or misleading information has become a top priority, says Andrew Wyatt, Chief Growth Officer, Sapio Sciences https://www.biosciencetoday.co.uk/ai-hallucinations-are-eroding-trust-in-lab-tools-but-there-are-solutions/

As scientists and researchers seek to integrate AI more deeply into daily lab workflows, tackling the issue of false or misleading information has become a top priority, says Andrew Wyatt, Chief Growth Officer, Sapio Sciences. AI is increasingly important for biopharma R&D, offering breakthroughs in...

19/02/2026

Claims the frontier of neurology has begun to think for itself, follow a pioneering brain surgery carried out at King Faisal Specialist Hospital & Research Centre https://www.biosciencetoday.co.uk/how-an-ai-powered-implant-is-rewriting-neurological-care/

The frontier of neurology has begun to think for itself. The claim follows pioneering brain surgery carried out at King Faisal Specialist Hospital and Research Centre (KFSHRC). In June 2025, surgeons at the centre, in Riyadh, Saudi Arabia, implanted the Middle East’s first AI powered smart brain d...